Peijun Cao Qingchun Zhao Yongwen Li Ruifeng Shi Guangsheng Zhu Zihe Zhang Hongbing Zhang Minghui Liu Sen Wei Hongyu Liu Jun Chen
10.3389/fphar.2023.1140894
Front Pharmacol
2023 Aug 17;14:1140894.
eml4-alk fusion gene alectinib neoadjuvant therapy pseudoresistance pulmonary adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/37663243/
Case Reports
PMC10470069
37663243
Case Report: ALK rearranged locally advanced lung adenocarcinoma showing inconsistent radiographic findings and pathological responses during neoadjuvant alectinib therapy
2023